Literature DB >> 2894398

Specific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis vulgaris.

A Ozawa1, M Ohkido, H Inoko, A Ando, K Tsuji.   

Abstract

In psoriasis vulgaris, the HLA class I Cw6 specificity has previously been recognized as the most commonly associated antigen serologically. This study was carried out to investigate whether or not the gene controlling the susceptibility to psoriasis vulgaris existed on the HLA, especially the HLA-C region. At first, we analyzed the restriction fragment length polymorphism (RFLP) of 13 patients with psoriasis vulgaris and 6 healthy controls who were all positive for at least one allele of HLA-Cw6. To characterize RFLP in psoriasis patients who did not have HLA-Cw6, 12 patients and 10 healthy controls who had HLA-Cw7 were also examined. Southern hybridization of genomic DNA demonstrated that DNA polymorphisms of the HLA-C antigen gene could not be found in any psoriasis vulgaris patient whether HLA-Cw6 or Cw7. However, a 4.5 kb BamHI fragment and a 3.1 kb PstI fragment were lacking in some healthy controls who had either HLA-Cw6 or Cw7. This study suggests that the presence of RFLP in the HLA-C gene is associated with psoriasis vulgaris. These specific fragments may help predispose individuals to psoriasis vulgaris, or may be essential for the development of the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894398     DOI: 10.1111/1523-1747.ep12456500

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201.

Authors:  I Ikaheimo; S Silvennoinen-Kassinen; J Karvonen; T Jarvinen; A Tiilikainen
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

3.  Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis.

Authors:  H Nakagawa; S Akazaki; A Asahina; K Tokunaga; K Matsuki; S Kuwata; Y Ishibashi; T Juji
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Identification in the HLA class I region of a gene expressed late in keratinocyte differentiation.

Authors:  Y Zhou; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  Allele-specific peptide ligand motifs of HLA-C molecules.

Authors:  K Falk; O Rötzschke; B Grahovac; D Schendel; S Stevanović; V Gnau; G Jung; J L Strominger; H G Rammensee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

6.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Authors:  J Zemmour; P Parham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

7.  Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide.

Authors:  Philip E Stuart; Lam C Tsoi; Rajan P Nair; Manju Ghosh; Madhulika Kabra; Pakeeza A Shaiq; Ghazala K Raja; Raheel Qamar; B K Thelma; Matthew T Patrick; Anita Parihar; Sonam Singh; Sujay Khandpur; Uma Kumar; Michael Wittig; Frauke Degenhardt; Trilokraj Tejasvi; John J Voorhees; Stephan Weidinger; Andre Franke; Goncalo R Abecasis; Vinod K Sharma; James T Elder
Journal:  HGG Adv       Date:  2021-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.